TLR3-mediated CD8+ dendritic cell activation is coupled with establishment of a cell-intrinsic antiviral state

Journal of Immunology

Volumn 195, Issue 3, 2015, Pages 1025-1033

  Széles, Lajos ^a   Meissner, Felix ^b   Dunand Sauthier, Isabelle ^a   Thelemann, Christoph ^c   Hersch, Micha ^c   Singovski, Simon ^a   Haller, Sergio ^c   Gobet, Florian ^a   Marraco, Silvia A Fuertes ^c   Mann, Matthias ^b   Garcin, Dominique ^a   Acha Orbea, Hans ^c   Reith, Walter ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; INTERFERON; TOLL LIKE RECEPTOR 8; ALPHA BETA INTERFERON RECEPTOR; IFNAR1 PROTEIN, MOUSE; POLYINOSINIC POLYCYTIDYLIC ACID; TLR3 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 3;

ANIMAL CELL; ARTICLE; CD8+ T LYMPHOCYTE; CELL MIGRATION; CELL PROTECTION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; GENE FUNCTION; MASS SPECTROMETRY; MOUSE; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHINOVIRUS INFECTION; SENDAI VIRUS INFECTION; T LYMPHOCYTE ACTIVATION; VESICULAR STOMATITIS INDIANA VIRUS; ANIMAL; C57BL MOUSE; CROSS PRESENTATION; GENETICS; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; PICORNAVIRUS INFECTION; RHINOVIRUS; SENDAI VIRUS; VIROLOGY;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CROSS-PRIMING; DENDRITIC CELLS; HUMANS; INTERFERON-BETA; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PICORNAVIRIDAE INFECTIONS; POLY I-C; RECEPTOR, INTERFERON ALPHA-BETA; RHINOVIRUS; SENDAI VIRUS; TOLL-LIKE RECEPTOR 3; VESICULAR STOMATITIS INDIANA VIRUS;

EID: 84937718267     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402033     Document Type: Article

References (52)

1. Satpathy, A. T., X. Wu, J. C. Albring, and K. M. Murphy. 2012. Re(de)fining the dendritic cell lineage. Nat. Immunol. 13: 1145-1154.
2. Shortman, K., and S. H. Naik. 2007. Steady-state and inflammatory dendriticcell development. Nat. Rev. Immunol. 7: 19-30.
3. Villadangos, J. A., and P. Schnorrer. 2007. Intrinsic and cooperative antigenpresenting functions of dendritic-cell subsets in vivo. Nat. Rev. Immunol. 7: 543-555.
4. Mildner, A., and S. Jung. 2014. Development and function of dendritic cell subsets. Immunity 40: 642-656.
5. Immunological Genome Consortium. 2012. Deciphering the transcriptional network of the dendritic cell lineage. Nat. Immunol. 13: 888-899.
6. den Haan, J. M., S. M. Lehar, and M. J. Bevan. 2000. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 192: 1685-1696.
7. Shortman, K., and W. R. Heath. 2010. The CD8+ dendritic cell subset. Immunol. Rev. 234: 18-31.
8. Kurts, C., B. W. Robinson, and P. A. Knolle. 2010. Cross-priming in health and disease. Nat. Rev. Immunol. 10: 403-414.
9. Dudziak, D., A. O. Kamphorst, G. F. Heidkamp, V. R. Buchholz, C. Trumpfheller, S. Yamazaki, C. Cheong, K. Liu, H. W. Lee, C. G. Park, et al. 2007. Differential antigen processing by dendritic cell subsets in vivo. Science 315: 107-111.
10. Lauterbach, H., B. Bathke, S. Gilles, C. Traidl-Hoffmann, C. A. Luber, G. Fejer, M. A. Freudenberg, G. M. Davey, D. Vremec, A. Kallies, et al. 2010. Mouse CD8alpha+ DCs and human BDCA3+ DCs are major producers of IFN-lambda in response to poly IC. J. Exp. Med. 207: 2703-2717.
11. Schulz, O., S. S. Diebold, M. Chen, T. I. Näslund, M. A. Nolte, L. Alexopoulou, Y. T. Azuma, R. A. Flavell, P. Liljeström, and C. Reis e Sousa. 2005. Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 433: 887-892.
12. Mashayekhi, M., M. M. Sandau, I. R. Dunay, E. M. Frickel, A. Khan, R. S. Goldszmid, A. Sher, H. L. Ploegh, T. L. Murphy, L. D. Sibley, and K. M. Murphy. 2011. CD8a(+) dendritic cells are the critical source of interleukin-12 that controls acute infection by Toxoplasma gondii tachyzoites. Immunity 35: 249-259.
13. Dalod, M., T. Hamilton, R. Salomon, T. P. Salazar-Mather, S. C. Henry, J. D. Hamilton, and C. A. Biron. 2003. Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon alpha/beta. J. Exp. Med. 197: 885-898.
14. Helft, J., B. Manicassamy, P. Guermonprez, D. Hashimoto, A. Silvin, J. Agudo, B. D. Brown, M. Schmolke, J. C. Miller, M. Leboeuf, et al. 2012. Cross-presenting CD103+ dendritic cells are protected from influenza virus infection. J. Clin. Invest. 122: 4037-4047.
15. Desmet, C. J., and K. J. Ishii. 2012. Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination. Nat. Rev. Immunol. 12: 479-491.
16. Kawai, T., and S. Akira. 2010. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11: 373-384.
17. Alexopoulou, L., A. C. Holt, R. Medzhitov, and R. A. Flavell. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413: 732-738.
18. Gauzzi, M. C., M. Del Cornò, and S. Gessani. 2010. Dissecting TLR3 signalling in dendritic cells. Immunobiology 215: 713-723.
19. Amit, I., M. Garber, N. Chevrier, A. P. Leite, Y. Donner, T. Eisenhaure, M. Guttman, J. K. Grenier,W. Li, O. Zuk, et al. 2009. Unbiased reconstruction of a mammalian transcriptional network mediating pathogen responses. Science 326: 257-263.
20. Chevrier, N., P. Mertins, M. N. Artyomov, A. K. Shalek, M. Iannacone, M. F. Ciaccio, I. Gat-Viks, E. Tonti, M. M. DeGrace, K. R. Clauser, et al. 2011. Systematic discovery of TLR signaling components delineates viral-sensing circuits. Cell 147: 853-867.
21. Cella, M., M. Salio, Y. Sakakibara, H. Langen, I. Julkunen, and A. Lanzavecchia. 1999. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. 189: 821-829.
22. Jelinek, I., J. N. Leonard, G. E. Price, K. N. Brown, A. Meyer-Manlapat, P. K. Goldsmith, Y. Wang, D. Venzon, S. L. Epstein, and D. M. Segal. 2011. TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-presentation, CTL responses, and antiviral protection. J. Immunol. 186: 2422-2429.
23. Doyle, S., S. Vaidya, R. O'Connell, H. Dadgostar, P. Dempsey, T. Wu, G. Rao, R. Sun, M. Haberland, R. Modlin, and G. Cheng. 2002. IRF3 mediates a TLR3/ TLR4-specific antiviral gene program. Immunity 17: 251-263.
24. MacMicking, J. D. 2012. Interferon-inducible effector mechanisms in cellautonomous immunity. Nat. Rev. Immunol. 12: 367-382.
25. Schoggins, J. W., and C. M. Rice. 2011. Interferon-stimulated genes and their antiviral effector functions. Curr Opin Virol 1: 519-525.
26. Doyle, S. E., R. O'Connell, S. A. Vaidya, E. K. Chow, K. Yee, and G. Cheng. 2003. Toll-like receptor 3 mediates a more potent antiviral response than Tolllike receptor 4. J. Immunol. 170: 3565-3571.
27. Gaajetaan, G. R., T. H. Geelen, G. E. Grauls, C. A. Bruggeman, and F. R. Stassen. 2012. CpG and poly(I:C) stimulation of dendritic cells and fibroblasts limits herpes simplex virus type 1 infection in an IFNb-dependent and -independent way. Antiviral Res. 93: 39-47.
28. Kramer, M., B. M. Schulte, L. W. Toonen, P. M. Barral, P. B. Fisher, K. H. Lanke, J. M. Galama, F. J. van Kuppeveld, and G. J. Adema. 2008. Phagocytosis of picornavirus-infected cells induces an RNA-dependent antiviral state in human dendritic cells. J. Virol. 82: 2930-2937.
29. Wang, N., Y. Liang, S. Devaraj, J.Wang, S. M. Lemon, and K. Li. 2009. Toll-like receptor 3 mediates establishment of an antiviral state against hepatitis C virus in hepatoma cells. J. Virol. 83: 9824-9834.
30. Kramer, M., B. M. Schulte, D. Eleveld-Trancikova, M. van Hout-Kuijer, L. W. Toonen, J. Tel, I. J. de Vries, F. J. van Kuppeveld, B. J. Jansen, and G. J. Adema. 2010. Cross-talk between human dendritic cell subsets influences expression of RNA sensors and inhibits picornavirus infection. J. Innate Immun. 2: 360-370.
31. Hildner, K., B. T. Edelson, W. E. Purtha, M. Diamond, H. Matsushita, M. Kohyama, B. Calderon, B. U. Schraml, E. R. Unanue, M. S. Diamond, et al. 2008. Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science 322: 1097-1100.
32. Luber, C. A., J. Cox, H. Lauterbach, B. Fancke, M. Selbach, J. Tschopp, S. Akira, M. Wiegand, H. Hochrein, M. O'Keeffe, and M. Mann. 2010. Quantitative proteomics reveals subset-specific viral recognition in dendritic cells. Immunity 32: 279-289.
33. Fuertes Marraco, S. A., F. Grosjean, A. Duval, M. Rosa, C. Lavanchy, D. Ashok, S. Haller, L. A. Otten, Q. G. Steiner, P. Descombes, et al. 2012. Novel murine dendritic cell lines: a powerful auxiliary tool for dendritic cell research. Front. Immunol. 3: 331.
34. Steiner, Q. G., L. A. Otten, M. J. Hicks, G. Kaya, F. Grosjean, E. Saeuberli, C. Lavanchy, F. Beermann, K. L. McClain, and H. Acha-Orbea. 2008. In vivo transformation of mouse conventional CD8alpha+ dendritic cells leads to progressive multisystem histiocytosis. Blood 111: 2073-2082.
35. Tsapogas, P., L. K. Swee, A. Nusser, N. Nuber, M. Kreuzaler, G. Capoferri, H. Rolink, R. Ceredig, and A. Rolink. 2014. In vivo evidence for an instructive role of fms-like tyrosine kinase-3 (FLT3) ligand in hematopoietic development. Haematologica 99: 638-646.
36. Mottet-Osman, G., F. Iseni, T. Pelet, M. Wiznerowicz, D. Garcin, and L. Roux. 2007. Suppression of the Sendai virus M protein through a novel short interfering RNA approach inhibits viral particle production but does not affect viral RNA synthesis. J. Virol. 81: 2861-2868.
37. Geiss, G. K., R. E. Bumgarner, B. Birditt, T. Dahl, N. Dowidar, D. L. Dunaway, H. P. Fell, S. Ferree, R. D. George, T. Grogan, et al. 2008. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat. Biotechnol. 26: 317-325.
38. Weber, F., V. Wagner, S. B. Rasmussen, R. Hartmann, and S. R. Paludan. 2006. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J. Virol. 80: 5059-5064.
39. Fuertes Marraco, S. A., C. L. Scott, P. Bouillet, A. Ives, S. Masina, D. Vremec, E. S. Jansen, L. A. O'Reilly, P. Schneider, N. Fasel, et al. 2011. Type I interferon drives dendritic cell apoptosis via multiple BH3-only proteins following activation by PolyIC in vivo. PLoS ONE 6: e20189.
40. Xu, Y., Y. Zhan, A. M. Lew, S. H. Naik, and M. H. Kershaw. 2007. Differential development of murine dendritic cells by GM-CSF versus Flt3 ligand has implications for inflammation and trafficking. J. Immunol. 179: 7577-7584.
41. Kumar, H., S. Koyama, K. J. Ishii, T. Kawai, and S. Akira. 2008. Cutting edge: cooperation of IPS-1- and TRIF-dependent pathways in poly IC-enhanced antibody production and cytotoxic T cell responses. J. Immunol. 180: 683-687.
42. Joffre, O., M. A. Nolte, R. Spö rri, and C. Reis e Sousa. 2009. Inflammatory signals in dendritic cell activation and the induction of adaptive immunity. Immunol. Rev. 227: 234-247.
43. Spörri, R., and C. Reis e Sousa. 2005. Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function. Nat. Immunol. 6: 163-170.
44. Swiecki, M., and M. Colonna. 2011. Type I interferons: diversity of sources, production pathways and effects on immune responses. Curr. Opin. Virol. 1: 463-475.
45. Honda, K., S. Sakaguchi, C. Nakajima, A. Watanabe, H. Yanai, M. Matsumoto, T. Ohteki, T. Kaisho, A. Takaoka, S. Akira, et al. 2003. Selective contribution of IFN-Alpha/beta signaling to the maturation of dendritic cells induced by doublestranded RNA or viral infection. Proc. Natl. Acad. Sci. USA 100: 10872-10877.
46. Longhi, M. P., C. Trumpfheller, J. Idoyaga, M. Caskey, I. Matos, C. Kluger, A. M. Salazar, M. Colonna, and R. M. Steinman. 2009. Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant. J. Exp. Med. 206: 1589-1602.
47. Donnelly, R. P., and S. V. Kotenko. 2010. Interferon-lambda: a new addition to an old family. J. Interferon Cytokine Res. 30: 555-564.
48. Schoggins, J. W., S. J. Wilson, M. Panis, M. Y. Murphy, C. T. Jones, P. Bieniasz, and C. M. Rice. 2011. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472: 481-485.
49. Pichlmair, A., C. Lassnig, C. A. Eberle, M. W. Górna, C. L. Baumann, T. R. Burkard, T. Bürckstümmer, A. Stefanovic, S. Krieger, K. L. Bennett, et al. 2011. IFIT1 is an antiviral protein that recognizes 59-triphosphate RNA. Nat. Immunol. 12: 624-630.
50. Lee, M. S., B. Kim, G. T. Oh, and Y. J. Kim. 2013. OASL1 inhibits translation of the type I interferon-regulating transcription factor IRF7. Nat. Immunol. 14: 346-355.
51. Taylor, R. T., K. J. Lubick, S. J. Robertson, J. P. Broughton, M. E. Bloom, W. A. Bresnahan, and S. M. Best. 2011. TRIM79a, an interferon-stimulated gene product, restricts tick-borne encephalitis virus replication by degrading the viral RNA polymerase. Cell Host Microbe 10: 185-196.
52. Takaoka, A., Z. Wang, M. K. Choi, H. Yanai, H. Negishi, T. Ban, Y. Lu, M. Miyagishi, T. Kodama, K. Honda, et al. 2007. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448: 501-505.